A pair of drugmakers priced their initial public offerings on Thursday, delivering the best month for US health care ...
Drug developer Maze Therapeutics said on Monday it was targeting a valuation of up to $728.1 million in its New York initial ...
An international team of scientists have discovered that soap could be important to helping our understanding of complex ...
An anonymous coder, writing to 404media under the fake name Aaron B, has also been feeling the malaise, and he's doing ...
Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that could make the kidney disease drug developer the first U.S. biotech ...
Maze Therapeutics, Inc MAZE IPO will take place January, 31 on the NASDAQ exchange under the ticker MAZE. The company is offering shares at an expected price between $15.00 and $17.00 per share with ...
Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a ...
Until this year, the Guinness World Record was held by a nearly 13,000-square-foot ice labyrinth in New York that took the ...
Rumors of ICE raids in the first week of Trump's presidency rattled a community that's been preparing for the his promise of ...
A small-scale homeless outreach program that Mayor Adams’ administration launched in late 2022 has proven effective. But the ...
The overhead view is of me in a maze.” I don’t know what it says about me that the great Trey Anastasio and Tom Marshall of ...
Today: a conversation with California Insurance Commissioner Ricardo Lara about gaps in insurance and what the road to ...